Beta-Amyloid (1-39)

Aβ1-39 is a C-terminally shortened amyloid-beta species that preserves most of the hydrophobic C-terminal region. It provides a defined comparator for Aβ40 and Aβ42 aggregation and analytical studies.

• amyloid-beta aggregation research
• Alzheimer disease research
• sequence/control studies
• biochemical assay development

Exact fragment boundaries, sequence order and N-terminal chemistry can materially alter Aβ solubility, aggregation and recognition. Treat this construct as a distinct reagent and use matched controls.

1. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging